Nature Communications (Aug 2024)

CDK12 controls transcription at damaged genes and prevents MYC-induced transcription-replication conflicts

  • Laura Curti,
  • Sara Rohban,
  • Nicola Bianchi,
  • Ottavio Croci,
  • Adrian Andronache,
  • Sara Barozzi,
  • Michela Mattioli,
  • Fernanda Ricci,
  • Elena Pastori,
  • Silvia Sberna,
  • Simone Bellotti,
  • Anna Accialini,
  • Roberto Ballarino,
  • Nicola Crosetto,
  • Mark Wade,
  • Dario Parazzoli,
  • Stefano Campaner

DOI
https://doi.org/10.1038/s41467-024-51229-5
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 18

Abstract

Read online

Abstract The identification of genes involved in replicative stress is key to understanding cancer evolution and to identify therapeutic targets. Here, we show that CDK12 prevents transcription-replication conflicts (TRCs) and the activation of cytotoxic replicative stress upon deregulation of the MYC oncogene. CDK12 was recruited at damaged genes by PARP-dependent DDR-signaling and elongation-competent RNAPII, to repress transcription. Either loss or chemical inhibition of CDK12 led to DDR-resistant transcription of damaged genes. Loss of CDK12 exacerbated TRCs in MYC-overexpressing cells and led to the accumulation of double-strand DNA breaks, occurring between co-directional early-replicating regions and transcribed genes. Overall, our data demonstrate that CDK12 protects genome integrity by repressing transcription of damaged genes, which is required for proper resolution of DSBs at oncogene-induced TRCs. This provides a rationale that explains both how CDK12 deficiency can promote tandem duplications of early-replicated regions during tumor evolution, and how CDK12 targeting can exacerbate replicative-stress in tumors.